Home › Compare › BVXV vs O

BVXV vs O: Dividend Comparison 2026

BVXV yields 147.06% · O yields 5.97%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BVXV wins by $22.58M in total portfolio value
10 years
BVXV
BVXV
● Live price
147.06%
Share price
$1.36
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.60M
Annual income
$9,667,205.19
Full BVXV calculator →
O
Realty Income Corporation
● Live price
5.97%
Share price
$52.30
Annual div
$3.12
5Y div CAGR
3.2%
Payout ratio
76%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.7K
Annual income
$1,416.15
Full O calculator →

Portfolio growth — BVXV vs O

📍 BVXV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBVXVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BVXV + O cover 8 of 12 months — good coverage

Jan
O
Feb
O
Mar
—
Apr
—
May
—
Jun
—
Jul
O
Aug
O
Sep
O
Oct
O
Nov
O
Dec
O
BVXV pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BVXV
Annual income on $10K today (after 15% tax)
$12,500.00/yr
After 10yr DRIP, annual income (after tax)
$8,217,124.41/yr
O
Annual income on $10K today (after 15% tax)
$507.07/yr
After 10yr DRIP, annual income (after tax)
$1,203.73/yr
At 15% tax rate, BVXV beats the other by $8,215,920.68/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BVXV + O for your $10,000?

BVXV: 50%O: 50%
100% O50/50100% BVXV
Portfolio after 10yr
$11.31M
Annual income
$4,834,310.67/yr
Blended yield
42.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

BVXV
No analyst data
Altman Z
-8.4
Piotroski
4/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+22.4% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BVXV buys
0
O buys
0
No recent congressional trades found for BVXV or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBVXVO
Forward yield147.06% ✓5.97%
Annual dividend / share$2.00$3.12 ✓
Payout ratio50% ✓76%
1-year div growth0%2.8% ✓
5-year div CAGR0%3.2% ✓
Portfolio after 10y$22.60M$22.7K ✓
Annual income after 10y$9,667,205.19 ✓$1,416.15
Total dividends collected$20.88M ✓$9.6K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: BVXV vs O ($10,000, DRIP)

YearBVXV PortfolioBVXV Income/yrO PortfolioO Income/yrGap
1← crossover$25,406$14,705.88$10,826$615.65+$14.6K → BVXV
2$62,102$34,917.38$11,727$673.66+$50.4K → BVXV
3$146,216$79,767.65$12,710$737.59+$133.5K → BVXV
4$331,975$175,523.78$13,785$808.08+$318.2K → BVXV
5$727,658$372,444.73$14,961$885.87+$712.7K → BVXV
6$1,541,551$762,956.42$16,247$971.76+$1.53M → BVXV
7$3,160,048$1,510,588.88$17,655$1,066.66+$3.14M → BVXV
8$6,275,251$2,893,998.93$19,197$1,171.57+$6.26M → BVXV
9$12,085,478$5,370,960.29$20,888$1,287.65+$12.06M → BVXV
10$22,598,667$9,667,205.19$22,743$1,416.15+$22.58M → BVXV

BVXV vs O: Complete Analysis 2026

BVXV — Stock

BiondVax Pharmaceuticals Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel.

Full BVXV Calculator →

O — REIT

Nicknamed 'The Monthly Dividend Company', Realty Income is a net-lease REIT with 15,000+ properties across the US and Europe. It has paid monthly dividends for 55+ consecutive years with 126 dividend increases since 1994 — a true Dividend Aristocrat. Its tenants include Walgreens, Dollar General, and FedEx. A cornerstone holding for income investors.

Full O Calculator →
📬

Get this BVXV vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BVXV vs SCHDBVXV vs JEPIBVXV vs KOBVXV vs MAINBVXV vs STAGBVXV vs ADCBVXV vs NNNBVXV vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.